| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/27/2009 | EP2061886A1 Small cationic antimicrobial peptides |
| 05/27/2009 | EP2061804A2 Pax2 and pax8 as targets for immunologic and molecular tumour treatment strategies |
| 05/27/2009 | EP2061512A1 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| 05/27/2009 | EP2061492A1 Method for ameliorating pain by modification of nmda receptors through inhibition of src |
| 05/27/2009 | EP2061491A2 Methods and compositions for conserving and/or preparing an organ or tissue for transplant |
| 05/27/2009 | EP2061488A2 Selectively targeted antimicrobial peptides and the use thereof |
| 05/27/2009 | EP1037651B1 Small peptides and methods for treatment of asthma and inflammation |
| 05/27/2009 | CN101443352A Novel analogues of antimicrobial and anticancer peptide synthesized and produced from Gaegurin 5 |
| 05/27/2009 | CN101443351A Modified molecules which promote hematopoiesis |
| 05/27/2009 | CN101440126A Acquisition and use of homing polypeptide with targeting specificity related to tumor and metastases thereof |
| 05/27/2009 | CN101440125A Novel process for synthesizing hexapeptide (TFA-Glu(OtBu)-Pro-Gly-Pro-Thr-Ala-OH) |
| 05/27/2009 | CN100491396C Selective cyclic peptides |
| 05/26/2009 | US7538190 cross metathesis; hydrogenation; stereoselective; synthesis of peptides with one or more intramolecular bridges |
| 05/26/2009 | US7538189 Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution |
| 05/26/2009 | US7538188 Method for fabricating an olfactory receptor-based biosensor |
| 05/26/2009 | US7538187 Coloring compositions with peptide-based dispersants and binders |
| 05/26/2009 | US7538091 D-retro-inverso amino acid sequence transporter peptide conjugated to nucleic acid biological effector; translocation across the membrane of pancreatic B-cells |
| 05/26/2009 | US7538089 Anti-inflammatory compounds and uses thereof |
| 05/26/2009 | US7538084 Cyclosporins |
| 05/26/2009 | US7538083 Compositions and methods for the potentiation of immune responses against target antigens |
| 05/22/2009 | WO2009063466A1 Compositions and methods for inhibiting hiv-1 replication and integrase activity |
| 05/22/2009 | WO2009062399A1 Peptide ligand directed drug delivery |
| 05/22/2009 | WO2009062238A1 Epitope for neutralizing antibodies |
| 05/22/2009 | WO2009015087A3 Compositions and methods for treatment of trauma |
| 05/22/2009 | WO2008148519A3 Mammalian expression vector with a highly efficient secretory signal sequence |
| 05/22/2009 | WO2006126188A3 Cxcr4 antagonists for wound healing and re-epithelialization |
| 05/21/2009 | US20090131634 Method for Preparing Cell Fraction Containing Hemangioblasts |
| 05/21/2009 | US20090131328 Furin inhibitors |
| 05/21/2009 | US20090131327 Nogo receptor functional motifs and peptide mimetics related thereto and methods of using the same |
| 05/21/2009 | US20090131326 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131324 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131321 Method of reducing injury to mammalian cells |
| 05/21/2009 | US20090131320 Peptides modulating the activity of the engrailed transcription factor |
| 05/21/2009 | US20090131317 Compounds and peptides that bind the trail receptor |
| 05/21/2009 | US20090131314 Thrombospondin-1 Derived Peptides and Treatment Methods |
| 05/21/2009 | US20090131277 Prostate cancer diagnosis and treatment |
| 05/21/2009 | US20090131266 Nucleic Acid-Like Proteins |
| 05/21/2009 | US20090130695 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
| 05/21/2009 | US20090130691 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
| 05/21/2009 | US20090130676 Interaction trap systems for detecting protein interactions |
| 05/21/2009 | US20090130134 T CD4+ Epitopes of Type I and II Latency Antigens of the Epstein-Barr Virus, Which Can Be Recognized by the majority of individuals in the caucasian populations and applications thereof |
| 05/21/2009 | US20090130133 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof |
| 05/21/2009 | US20090130129 Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/diagnostic use |
| 05/21/2009 | US20090130107 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 05/20/2009 | EP2060628A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 05/20/2009 | EP2060585A2 Gene regulatory peptides |
| 05/20/2009 | EP2059256A1 Immunogenic peptides and their use in immune disorders |
| 05/20/2009 | EP1562620B1 Modified cytokines for use in cancer therapy |
| 05/20/2009 | EP1163260B1 Process for partitioning of proteins |
| 05/20/2009 | CN101434650A Bursa pentapeptide, deriving peptide thereof and use thereof |
| 05/20/2009 | CN101434649A Small peptide, preparation thereof and use thereof in diagnosis or treatment of PACAP and VIP related diseases |
| 05/20/2009 | CN101434648A Peptide for inhibiting angiogenesis, and use thereof in angiogenesis medicament preparation |
| 05/20/2009 | CN101434647A Epitope/peptide recognized by hla-a2402-restricted ep/cam-specific ctl and use of the same |
| 05/20/2009 | CN100489114C Low-cost production for peptides |
| 05/20/2009 | CN100488981C Proaerolysin containing protease activation sequences and its uses |
| 05/20/2009 | CN100488563C Modified anti-EGFR antibody with reduced immunogenicity |
| 05/20/2009 | CN100488560C Method for preparing mass micro-capsule |
| 05/19/2009 | US7534858 For therapy of inflammatory disorders; polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence |
| 05/19/2009 | US7534857 Methods and compositions for the treatment and prevention of staphylococcal infections |
| 05/19/2009 | US7534776 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 05/19/2009 | US7534761 Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom |
| 05/19/2009 | US7534441 Immunogenic LHRH compositions and methods relating thereto |
| 05/19/2009 | CA2323237C Improved radiation therapy methods |
| 05/14/2009 | WO2009059804A2 T-cell receptor peptides specific for part of cd20, uses thereof, and methods of preparing cytotoxic t-cells |
| 05/14/2009 | WO2009059450A1 Peptide ligand directed drug delivery |
| 05/14/2009 | WO2008132738A3 Anticancerous polymeric agents |
| 05/14/2009 | WO2007059000A3 Modulation of angiogenesis by a-beta peptide fragments |
| 05/14/2009 | US20090124556 Peptides Exhibiting Efficacies of Improvement in Skin Conditions or Treatment of Periodental Diseases |
| 05/14/2009 | US20090124555 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
| 05/14/2009 | US20090124549 administering to a patient infected with mycobacterium tuberculosis, a therapeutically effective amount of an isolated polypeptide ( a polypeptide covalently linked to a carrier); protective immune response |
| 05/14/2009 | US20090124538 Selective R-cadherin antagonists and methods |
| 05/14/2009 | US20090124008 Peptides for use in culture media |
| 05/14/2009 | US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
| 05/14/2009 | US20090123920 Jak2 mutations |
| 05/14/2009 | US20090123489 Novel immunotherapy against neuronal and brain tumors |
| 05/14/2009 | US20090123477 Antibodies |
| 05/14/2009 | US20090123463 Methods and compositions for inducing apoptosis |
| 05/14/2009 | US20090123459 Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease |
| 05/14/2009 | US20090123445 Surfactin-Containing Compositions for Controlling Scab Disease in Agricultural Products |
| 05/14/2009 | US20090123370 Alphavbeta6 peptide ligands and their uses |
| 05/14/2009 | DE10163130B4 Apoptotisch wirksame Peptide und diese umfassende pharmazeutische Zusammensetzungen Apoptotic active peptides and pharmaceutical compositions comprising |
| 05/13/2009 | EP2058399A1 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 05/13/2009 | EP2058328A1 Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 05/13/2009 | EP2058323A1 Tumour-associated peptides which bind to MHC molecules |
| 05/13/2009 | EP2058320A1 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 05/13/2009 | EP2058005A1 Inoculant for treating coeliac disease and method for producing the inoculant, application of a peptide sequence joined with a bacterial toxin for activating the immune system against prolamine and designer peptide |
| 05/13/2009 | EP2057185A1 Polymyxin derivatives and uses thereof |
| 05/13/2009 | EP2057184A2 Cyclic angiotensin analogs |
| 05/13/2009 | EP2056886A2 68ga-labeled peptide-based radiopharmaceuticals |
| 05/13/2009 | EP1320540B1 Peptidomimetic protease inhibitors |
| 05/13/2009 | CN101432295A Peptide |
| 05/13/2009 | CN101432294A Compounds analogous to growth hormone peptide secretagogues and preparations containing them |
| 05/13/2009 | CN101429239A Anti-atherosis epitope composition, preparation method and uses thereof |
| 05/13/2009 | CN101429235A New high-efficiency low-toxicity actinomycin type D antineoplastic compound |
| 05/13/2009 | CN101429234A Vaccine based on simulating human blood vessel endothelial cell growth factor VEGF epitope and preparation method thereof |
| 05/13/2009 | CN101429233A Polyglycol modified antimicrobial peptide and uses thereof |
| 05/13/2009 | CN100486995C Compositions and methods for WT1 specific immunotherapy |
| 05/13/2009 | CN100486992C Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 05/13/2009 | CN100486991C Screening and authentication of polypeptide binding specificly to tumour tranferring cell |
| 05/12/2009 | US7531623 Such as of telavancin isolated via precipitation, filtration; storage stability |